AUGUSTINE LAWLOR

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for Augustine Lawlor
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by AUGUSTINE LAWLOR:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEAP THERAPEUTICS, INC. Chief Operating Officer Common Stock 678,456 $214,799 $0.3166 28 Mar 2025 Indirect
LEAP THERAPEUTICS, INC. Chief Operating Officer Common Stock 19,789 $6,265 $0.3166 28 Mar 2025 Direct
LEAP THERAPEUTICS, INC. Chief Operating Officer Restricted Stock Units 0 $0 $0.3166 28 Mar 2025 Direct
LEAP THERAPEUTICS, INC. Chief Operating Officer Employee Stock Option (Right to Buy) 85,000 02 Oct 2024 Direct
Cardiovascular Systems Inc Director Common Stock 0 $20.00 27 Apr 2023 By Lawlor Family Trust
Cardiovascular Systems Inc Director Common Stock 0 $20.00 27 Apr 2023 Direct
Cardiovascular Systems Inc Director Restricted Stock Units 0 27 Apr 2023 Direct
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 31 Aug 2023 By The Lawlor Family Trust UAD 4-17-00
CATALYST BIOSCIENCES, INC. Director Series Y Preferred Stock 0 31 Aug 2023 Direct
LEAP THERAPEUTICS, INC. Chief Operating Officer Warrant (Right to Buy) 0 13 Nov 2024 Indirect

Insider Reports Filed by AUGUSTINE LAWLOR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LPTX LEAP THERAPEUTICS, INC. 30 Jun 2025 0 $0 4 Chief Operating Officer 01 Jul 2025, 16:30
LPTX LEAP THERAPEUTICS, INC. 28 Mar 2025 3 -$2,469 4 Chief Operating Officer 01 Apr 2025, 21:53
LPTX LEAP THERAPEUTICS, INC. 13 Nov 2024 2 +$6,024 4 Chief Operating Officer 15 Nov 2024, 17:29
LPTX LEAP THERAPEUTICS, INC. 02 Oct 2024 1 $0 4 Chief Operating Officer 04 Oct 2024, 17:24
LPTX LEAP THERAPEUTICS, INC. 29 Jan 2024 1 $0 4 Chief Operating Officer 31 Jan 2024, 21:34
LPTX LEAP THERAPEUTICS, INC. 26 Jan 2024 2 $0 4 Chief Operating Officer 30 Jan 2024, 20:38
GYRE CATALYST BIOSCIENCES, INC. 31 Aug 2023 2 $0 4 Director 01 Sep 2023, 17:07
LPTX LEAP THERAPEUTICS, INC. 23 Aug 2023 1 $0 4 Chief Operating Officer 25 Aug 2023, 17:31
/report/000106299323009600-lawlor-augustine-2023-04-27 Cardiovascular Systems Inc 27 Apr 2023 3 -$606,800 4 Director 27 Apr 2023, 16:34
LPTX LEAP THERAPEUTICS, INC. 31 Mar 2023 1 $0 4 Chief Operating Officer 04 Apr 2023, 20:09
LPTX LEAP THERAPEUTICS, INC. 01 Sep 2022 1 $0 4 Chief Operating Officer 02 Sep 2022, 21:26
/report/000143774922019615-lawlor-augustine-2022-08-05 Cardiovascular Systems Inc 05 Aug 2022 1 $0 4 Director 09 Aug 2022, 16:18
LPTX LEAP THERAPEUTICS, INC. 31 Jan 2022 1 $0 4 Chief Operating Officer, 10%+ Owner 02 Feb 2022, 20:49
/report/000091419021000411-lawlor-augustine-2021-11-15 Cardiovascular Systems Inc 15 Nov 2021 1 $0 4 Director 17 Nov 2021, 15:36
GYRE CATALYST BIOSCIENCES, INC. 01 Oct 2021 1 $0 4 Director 05 Oct 2021, 16:33
/report/000091419021000245-lawlor-augustine-2021-08-09 Cardiovascular Systems Inc 09 Aug 2021 2 $0 4 Director 11 Aug 2021, 19:19
GYRE CATALYST BIOSCIENCES, INC. 09 Jun 2021 2 $0 4 Director 02 Jul 2021, 09:54
LPTX LEAP THERAPEUTICS, INC. 26 May 2021 1 $0 4 Chief Operating Officer, 10%+ Owner 28 May 2021, 20:33